Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-05-11 00:00:00 ET · period of report 2022-05-09 · accession 0001765581-22-000049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-11 | 2022-05-09 | JAZZ | Larkin Finbar | SVP, Technical Ops | S - Sale | $148.94 | -1,747 | 19.5K | -8% | -$260.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-05-09 | S | D | 1,747 | $148.94 | 19,462 | D | — | — | (F2) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.92 to $149.91 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |